Detalhe da pesquisa
1.
Systemic amyloidoses.
Annu Rev Biochem
; 82: 745-74, 2013.
Artigo
Inglês
| MEDLINE | ID: mdl-23451869
2.
A proteomic atlas of kidney amyloidosis provides insights into disease pathogenesis.
Kidney Int
; 105(3): 484-495, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38096952
3.
Vesicular Stomatitis Virus Encoding a Destabilized Tumor Antigen Improves Activation of Anti-tumor T Cell Responses.
Mol Ther
; 28(12): 2540-2552, 2020 12 02.
Artigo
Inglês
| MEDLINE | ID: mdl-32877695
4.
Mechanistic Insights into the Early Events in the Aggregation of Immunoglobulin Light Chains.
Biochemistry
; 58(29): 3155-3168, 2019 07 23.
Artigo
Inglês
| MEDLINE | ID: mdl-31287666
5.
Clinical features, laboratory characteristics and outcomes of patients with renal versus cardiac light chain amyloidosis.
Br J Haematol
; 185(4): 701-707, 2019 05.
Artigo
Inglês
| MEDLINE | ID: mdl-30836444
6.
Clarifying immunoglobulin gene usage in systemic and localized immunoglobulin light-chain amyloidosis by mass spectrometry.
Blood
; 129(3): 299-306, 2017 Jan 19.
Artigo
Inglês
| MEDLINE | ID: mdl-27856462
7.
Differences in Protein Concentration Dependence for Nucleation and Elongation in Light Chain Amyloid Formation.
Biochemistry
; 56(5): 757-766, 2017 02 07.
Artigo
Inglês
| MEDLINE | ID: mdl-28074646
8.
Cell Damage in Light Chain Amyloidosis: FIBRIL INTERNALIZATION, TOXICITY AND CELL-MEDIATED SEEDING.
J Biol Chem
; 291(38): 19813-25, 2016 09 16.
Artigo
Inglês
| MEDLINE | ID: mdl-27462073
9.
B-type natriuretic peptide overexpression ameliorates hepatorenal fibrocystic disease in a rat model of polycystic kidney disease.
Kidney Int
; 92(3): 657-668, 2017 09.
Artigo
Inglês
| MEDLINE | ID: mdl-28416225
10.
Mesenchymal stromal cells protect human cardiomyocytes from amyloid fibril damage.
Cytotherapy
; 19(12): 1426-1437, 2017 12.
Artigo
Inglês
| MEDLINE | ID: mdl-29037943
11.
Assessment of renal response with urinary exosomes in patients with AL amyloidosis: A proof of concept.
Am J Hematol
; 92(6): 536-541, 2017 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-28295502
12.
Recruitment of Light Chains by Homologous and Heterologous Fibrils Shows Distinctive Kinetic and Conformational Specificity.
Biochemistry
; 55(21): 2967-78, 2016 05 31.
Artigo
Inglês
| MEDLINE | ID: mdl-27158939
13.
Differential effects on light chain amyloid formation depend on mutations and type of glycosaminoglycans.
J Biol Chem
; 290(8): 4953-4965, 2015 Feb 20.
Artigo
Inglês
| MEDLINE | ID: mdl-25538238
14.
Clonotypic Light Chain Peptides Identified for Monitoring Minimal Residual Disease in Multiple Myeloma without Bone Marrow Aspiration.
Clin Chem
; 62(1): 243-51, 2016 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-26430073
15.
Evaluation of the BH3-only protein Puma as a direct Bak activator.
J Biol Chem
; 289(1): 89-99, 2014 Jan 03.
Artigo
Inglês
| MEDLINE | ID: mdl-24265320
16.
Phenotyping polyclonal kappa and lambda light chain molecular mass distributions in patient serum using mass spectrometry.
J Proteome Res
; 13(11): 5198-205, 2014 Nov 07.
Artigo
Inglês
| MEDLINE | ID: mdl-25134970
17.
Nanoliposomes protect against AL amyloid light chain protein-induced endothelial injury.
J Liposome Res
; 24(1): 69-73, 2014 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-24236475
18.
Biophysical characterization of human-cell-expressed, full-length κI O18/O8, AL-09, λ6a, and Wil immunoglobulin light chains.
Biochim Biophys Acta Proteins Proteom
; 1872(3): 140993, 2024 May 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38169170
19.
Tyrosine residues mediate fibril formation in a dynamic light chain dimer interface.
J Biol Chem
; 287(33): 27997-8006, 2012 Aug 10.
Artigo
Inglês
| MEDLINE | ID: mdl-22740699
20.
MASS-FIX may allow identification of patients at risk for light chain amyloidosis before the onset of symptoms.
Am J Hematol
; 93(11): E368-E370, 2018 11.
Artigo
Inglês
| MEDLINE | ID: mdl-30105838